your partner in preclinical research

Latest Posts

> 2016 Feb

Urosphere will be present at the European Association of Urology congress 2016

Urosphere will be present at the International Continence Society 2017 will present two posters at the 31st annual EAU congress (13 March 2016 at 12:45 PM, room 14a): Immunotherapy to treat Bladder Painful Syndrome Development and validation of a clinically-relevant chronic model of Interstitial Cystitis / Bladder Painful Syndrome It will be a pleasure to meet you during the EAU congress. Don't hesitate to contact us.

Read more

> 2016 Jan

Urosphere will attend the toulouse oncoweek, to be held in toulouse, france, february 03-05, 2016.

We will have an oral communication on "Optical imaging in preclinical tumour models: helpful or pitfall?” on Friday, February 5th, 13:00-14:15
If you wish to meet Urosphere's managers during the meeting, please contact us.

Read more

> 2016 Jan

Urosphere and Ambiotis sign a strategic collaboration agreement

Urosphere and Ambiotis another Contract Research Organization, based in Toulouse, France announce a strategic partnership to broaden and strenghten their respective activities. Under this agreement, the two companies intend to combine their skills to offer an even more integrated approach to their customers. UROSPHERE will indeed bring its expertise in building physiological and pathological animal models within the uro-genital, gastro-intestinal and oncological areas while Ambiotis will offer its expertise in the molecular characterization of such models (inflammatory and pain mediators).

Read more

> 2016 Jan

Season’s Greetings and Best Wishes!

Read more

> 2015 Jun

UROSPHERE ANNOUNCES ISO 9001 CERTIFICATION.

Urosphere is pleased to announce another step in its commitment to the highest quality standards. Urosphere obtained the certification of its Quality Management System (QMS) ISO 9001: 2008 provided by Lloyd's Register Quality Assurance (LRQA), a world’s leading provider of certifications.  “Today, we become the first CRO specialized in preclinical pharmacology in the field of urogenital pathologies. We provide to our customers an internationally recognized certification of its QMS not only for the scientific side of our activity but also for the whole organization.” said Dr. Philippe LLUEL, Chief Executive Officer.

Demonstrating a real commitment to service quality, Urosphere applies on a daily bases the following principles:
- To provide customers the competency of our staff and high level of expertise,
- To listen and to adapt to specific needs,
- To guarantee a perfect traceability of our data,
- To become a privileged partner. Click here to see our certificate of approval: ISO 9001 certification

Read more